Literature DB >> 22504699

[Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel].

Kenji Okumura1, Souichiro Tani, Youji Shiogai, Masashi Kodama, Eiji Mekata, Tohru Tan.   

Abstract

We report two cases of advanced gastric cancer. The first was a 77-year-old man who had experienced distal gastrectomy about 35 years ago. He complained of abdominal bloating, and a gastrointestinal scope showed that he had advanced gastric cancer. CT scan revealed massive ascites. Dissemination of the peritoneum was suspected, and chemotherapy using S-1 (80mg/m², biweekly)plus paclitaxel (50mg/m², on days 1 and 8) was selected, He had no major side effects and the ascites disappeared. He was able to receive 18 courses on an outpatient basis. The second case was a 79-year-old man who had total gastrectomy performed 1 year ago. Invasion to the diaphragm and lymph node metastasis were detected. We selected S-1 (80 mg/m²)as adjuvant chemotherapy but that caused severe fatigue. Eventually he refused the drug. Six month later, he had abdominal bloating and CT scan revealed that he had massive ascites. UFT-E (1. 5 g/body) was administered and paclitaxe (l 50 mg/m²) was added. The ascites disappeared and he has had a stable life. DIF (S-1, UFT) plus paclitaxel is considered to be a useful chemotherapy combination against advanced gastric cancer that has peritoneal dissemination or ascites, even for older patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504699

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Long-term survival after sequential chemotherapy and surgery for advanced gastric cancer.

Authors:  Takashi Orii; Yukihiko Karasawa; Hiroe Kitahara; Masaki Yoshimura; Motohiro Okumura
Journal:  Int J Surg Case Rep       Date:  2013-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.